Wisconsin Alumni Research Foundation

Prestan Products LLC

Other

Michigan State University

United States of America, As Represented by the Secretary of Agriculture

Health O Meter, Inc.

Xenon Genetics Inc.

Cpr Prompt, L.l.c.

Complient Corporation

Preston Products LLC

Aovatechnologies, Inc.

Mark Eric Cook

Michael W Pariza

Jordan Marshall Sand

Daniel Elmer Butz

John J Pastrick

Timothy E Lint

Warren Paul Porter

Christopher E Bryniarski

Daria L Jerome

Fariba Masoumeh Assadi-Porter

Daniel R Moon

James M Ntambi

Lisa Ann Krugner-Higby

Yeonhwa Park

Julio L Pimentel

Cheryl C Miller

Mingder Yang

Danielle DeVoney

Christopher M Charlton

Elizabeth A Bobeck

Kimberly S Burgess

Keith H Crawford

Martin Petkovich

Brett Lovelady

Terence P Barry

Steven W Lindseth

Sandra Austin-Phillips

Richard J Straub

Richard G Koegel

R Richard Carpenter

Xiaoyun Yang

Leah D Whigham

Christian Helvig

Erica Hellestad

Kyle Swen

Curt Bingham

Donald Steele Lydic

Zhouzheng Ren

Jake M Olson

Hamid Reza Eghbalnia

Alexis Jo Piepenburg

Dennis R Buege

Michael R Hayden

Leonard S Girsh

Mark R Etzel

Alan D Attie

Daria Jerome

Christian F Helvig

Mark Gray-Keller

Craig C Weidman

Joseph F Moore

Simon N Pimstone

Janet R Jackson

Angela R Brooks-Wilson

Daniel J Wanhainen

Ricky L Monson

Bernard C Wentworth

Marco Tonelli

David M Barnes

Kisun N Lee

Paul Mozdziak

Frank M Graziano

James L Stahl

Ellen B Cook

David H Abbott

Mark S Kopaskie

Dale A Schoeller

Sohee Kim

Isabel W Treichel

Maria K Dashek

Sheila Mary McGuirk

Kevin Roberson

Jackie J Rutledge

Crague E Cook

Mike H Kogut

Niels Jorgensen

Guangming Li

Jane Ellen Rieman

Maria K Arendt

Christina L Swaggerty

Beth M Drake

Daniel Meilahn Schaefer

Ming-der Yang

Mitchell Raymond Schaefer

Sarah Marie Raabis

Larry Smith

Rahim Aydin

Hamid R Eghbalnia

James Mukasa Ntambi

Terrence P Barry

Airway cup assembly

Lung bag

Described herein are interleukin-10 receptor-2 peptides, antibodies that bind the peptides, compositions including the peptides and antibodies and methods of use of the peptides and antibodies. The interleukin-10 receptor-2 peptide consists of an 8-15 amino acid sequence that includes

Antibodies that bind interleukin-10 receptor-2 peptides, compositions, and methods of use thereof

Piston and lighted rate monitor

Described herein are peptides from secretory phospholipase A-IB and antibodies that can be used to reduce the contribution of the gastrointestinal tract to inflammatory processes including systemic inflammatory responses. Specifically, antibodies that bind specifically a peptide from secretory phospholipase A-IB prevent death in a mouse model of LPS-induced endotoxemia. The antibodies described herein are particularly useful to treat systemic inflammatory response syndromes, including sepsis.

Compositions and methods for the treatment of systemic inflammatory response syndromes

A method of making coated avian egg yolk cores includes providing dried avian egg yolk cores having a diameter of 100 to 1500 micrometers, applying avian egg albumen to the dried avian egg yolk cores to provide the coated avian egg yolk cores, and optionally drying the coated avian egg yolk cores, wherein the ratio of dry avian egg albumen to dried avian egg yolk in the coated avian egg yolk cores is 1:10 to 10:1. Also included are the coated avian egg yolk cores, food and feed additives containing the coated avian egg yolk cores and food and feed compositions containing the coated avian egg yolk cores.

Coated egg yolk cores, methods of making and methods of use thereof

Described herein are FGF-23 epitope peptides, methods of producing antibodies in laying hens by injecting the peptides, and methods of improving resistance to eggshell breakage and/or increasing eggshell strength by administering an FGF-23 epitope peptide to a laying hen.

Method for improving resistance to breakage and eggshell strength

Disclosed herein are methods of reducing a symptom of respiratory disease in a pre-weaned milk-fed mammal by orally administering an isolated antibody that specifically binds the interleukin-10 peptide or an anti-interleukin-10 antibody. Also included are methods of reducing mixing stress in human and non-human mammals by administering an isolated antibody that specifically binds the interleukin-10 peptide or an anti-interleukin-10 antibody. Further included are milk and food compositions including the interleukin-10 peptide or anti-interleukin-10 antibody.

Compositions and methods of use of interleukin-10 peptides and anti-interleukin-10 antibodies

Described herein are interleukin-10 receptor-2 peptides, antibodies that bind the peptides, compositions including the peptides and antibodies and methods of use of the peptides and antibodies. The interleukin-10 receptor-2 peptide consists of an 8-15 amino acid sequence that includes SEQ ID NO: 1 ((I/V)P(P/K/V/E)P(E/K/R/Q)N(A/V)R), SEQ ID NO: 2 ((S/L/V)PAF(A/P)(K/Q)(G/T/E)(N/T/D)), or SEQ ID NO: 3 (PP(G/T/Q/V)(V/T/A)(R/H/T/S)(GN/NHP/SAA)).

Interleukin-10 receptor-2 peptides, antibodies, compositions, and methods of use thereof

Described herein dog and cat food additives and compositions comprising secretory IgA.

Methods of use of secretory IgA

Disclosed are methods of altering metabolism of phosphate in a livestock via an antibody. The methods involve the development of an antibody against FGF-23 for the purpose of reducing phosphate excretion by an animal.

FGF-23 epitope peptides and methods of use thereof

Described herein are methods of determining energy balance in individuals such as exercising individuals, individuals consuming aC-enriched test composition and individuals consuming a fixed diet with a known &#x3b4;C. The &#x3b4;C pre- and post-exercise, or pre- and post-consumption of the test beverage or fixed diet indicate whether the individual is in neutral or positive energy balance, or in energy deficit. The methods are particularly useful for individuals participating in weight management programs, and individuals under the care of health care professionals.

Methods of determining energy balance using breath carbon isotope ratios

Described herein is secretory IgA isolated from the intestinal luminal fluid and intestinal mucosal of animals such as pigs and cows. Also included are methods of isolating secretory IgA. The secretory IgA is useful in food compositions such as animal and human food compositions as well as pharmaceutical compositions to increase growth rate, improve feed efficiency, reduce gastrointestinal inflammation, reduce a risk of gastrointestinal infection in the animal, or a combination thereof.

Secretory IgA compositions, methods of making and methods of use thereof

Described herein are methods of use of purified preen oil, food and feed compositions containing purified preen oil, food and feed additives containing purified preen oil, and pharmaceutical compositions containing purified preen oil. Methods include treatment of chronic joint inflammation in humans and animals by orally administering purified preen oil. Also included are methods of feeding a growing fish by feeding the feeding the growing fish purified preen oil in amounts effective to improve survival and/or stimulate growth in the growing fish. Further included are methods of feeding live prey organisms purified preen oil, and feeding the live prey organisms to growing fish.

Compositions containing preen oil and methods of use thereof

Growing community of inventors

Madison, WI, United States of America

Mark Eric Cook